Patent · US Active

Tricyclic PI3K inhibitor compounds and methods of use

US10435414B2 · kind B2 · utility

0Cited by
6References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 25, 2018
Grant dateOct 8, 2019
Priority date—
Expiry dateJul 25, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are tricyclic compounds with phosphoinositide-3 kinase (PI3K) modulation activity or function having the Formula I structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.